Chronic Circadian Disruption and Sleep Restriction Influence Subjective Hunger, Appetite, and Food Preference

por McHill, Andrew W., Hull, Joseph T., Klerman, Elizabeth B.
Publicado 2022

Chronic Insufficient Sleep Has a Limited Impact on Circadian Rhythmicity of Subjective Hunger and Awakening Fasted Metabolic Hormones

por McHill, Andrew W., Hull, Joseph T., McMullan, Ciaran J., Klerman, Elizabeth B.
Publicado 2018

Authors’ Reply to Singh and Balasundaram: Comment on “A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial Assessing the Efficacy and Safety of Viloxazine Extended-Relea...

por Nasser, Azmi, Hull, Joseph T., Liranso, Tesfaye, Fry, Nicholas, Cutler, Andrew J., Rubin, Jonathan, Childress, Ann
Publicado 2022

A post hoc analysis of the effect of viloxazine extended-release capsules on learning and school problems in children and adolescents with attention-deficit/hyperactivity disorder

por Faraone, Stephen V., Gomeni, Roberto, Hull, Joseph T., Busse, Gregory D., Melyan, Zare, Rubin, Jonathan, Nasser, Azmi
Publicado 2021

Response of peer relations and social activities to treatment with viloxazine extended‐release capsules (Qelbree(®)): A post hoc analysis of four randomized clinical trials of chil...

por Faraone, Stephen V., Gomeni, Roberto, Hull, Joseph T., Busse, Gregory D., Lujan, Brendan, Rubin, Jonathan, Nasser, Azmi
Publicado 2023

Executive Function Outcome of Treatment with Viloxazine Extended-Release Capsules in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Post-Hoc Analysis of...

por Faraone, Stephen V., Gomeni, Roberto, Hull, Joseph T., Busse, Gregory D., Melyan, Zare, Rubin, Jonathan, Nasser, Azmi
Publicado 2021

Sleep Restriction and Recurrent Circadian Disruption Differentially Affects Blood Pressure, Sodium Retention, and Aldosterone Secretion

por McMullan, Ciaran J., McHill, Andrew W., Hull, Joseph T., Wang, Wei, Forman, John P., Klerman, Elizabeth B.
Publicado 2022

The Effect of Viloxazine Extended-Release Capsules on Functional Impairments Associated with Attention-Deficit/Hyperactivity Disorder (ADHD) in Children and Adolescents in Four Pha...

por Nasser, Azmi, Hull, Joseph T, Liranso, Tesfaye, Busse, Gregory D, Melyan, Zare, Childress, Ann C, A Lopez, Frank, Rubin, Jonathan
Publicado 2021

The role of placebo response in the efficacy outcome assessment in viloxazine extended‐release pivotal trials in paediatric subjects with attention‐deficit/hyperactivity disorder...

por Nasser, Azmi, Gomeni, Roberto, Wang, Zhao, Hull, Joseph T., Busse, Gregory D., Melyan, Zare, Fava, Maurizio, O'Neal, Welton, Rubin, Jonathan
Publicado 2022

Evaluating the likelihood to be helped or harmed after treatment with viloxazine extended‐release in children and adolescents with attention‐deficit/hyperactivity disorder

por Nasser, Azmi, Kosheleff, Alisa R., Hull, Joseph T., Liranso, Tesfaye, Qin, Peibing, Busse, Gregory D., Fava, Maurizio, Maletic, Vladimir, Rubin, Jonathan, Lopez, Frank
Publicado 2021

Translating Attention-Deficit/Hyperactivity Disorder Rating Scale-5 and Weiss Functional Impairment Rating Scale-Parent Effectiveness Scores into Clinical Global Impressions Clinic...

por Nasser, Azmi, Kosheleff, Alisa R., Hull, Joseph T., Liranso, Tesfaye, Qin, Peibing, Busse, Gregory D., O'Neal, Welton, Fava, Maurizio, Faraone, Stephen V., Rubin, Jonathan
Publicado 2021

A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial Assessing the Efficacy and Safety of Viloxazine Extended-Release Capsules in Adults with Attention-Deficit/Hyperacti...

por Nasser, Azmi, Hull, Joseph T., Chaturvedi, Soumya A., Liranso, Tesfaye, Odebo, Oyinkansola, Kosheleff, Alisa R., Fry, Nicholas, Cutler, Andrew J., Rubin, Jonathan, Schwabe, Stefan, Childress, Ann
Publicado 2022

Analysis Method and Experimental Conditions Affect Computed Circadian Phase from Melatonin Data

por Klerman, Hadassa, St. Hilaire, Melissa A., Kronauer, Richard E., Gooley, Joshua J., Gronfier, Claude, Hull, Joseph T., Lockley, Steven W., Santhi, Nayantara, Wang, Wei, Klerman, Elizabeth B.
Publicado 2012

A Phase 3, Placebo-Controlled Trial of Once-Daily Viloxazine Extended-Release Capsules in Adolescents With Attention-Deficit/Hyperactivity Disorder

por Nasser, Azmi, Liranso, Tesfaye, Adewole, Toyin, Fry, Nicholas, Hull, Joseph T., Busse, Gregory D., Chowdhry, Fatima, Cutler, Andrew J., Jones, Nandita Joshi, Findling, Robert L., Schwabe, Stefan
Publicado 2021

Light modulates oscillatory alpha activity in the occipital cortex of totally visually blind individuals with intact non-image-forming photoreception

por Vandewalle, Gilles, van Ackeren, Markus J., Daneault, Véronique, Hull, Joseph T., Albouy, Geneviève, Lepore, Franco, Doyon, Julien, Czeisler, Charles A., Dumont, Marie, Carrier, Julie, Lockley, Steven W., Collignon, Olivier
Publicado 2018

Short-Wavelength Light Sensitivity of Circadian, Pupillary, and Visual Awareness in Humans Lacking an Outer Retina

por Zaidi, Farhan H., Hull, Joseph T., Peirson, Stuart N., Wulff, Katharina, Aeschbach, Daniel, Gooley, Joshua J., Brainard, George C., Gregory-Evans, Kevin, Rizzo, Joseph F., Czeisler, Charles A., Foster, Russell G., Moseley, Merrick J., Lockley, Steven W.
Publicado 2007